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1. Introduction 
Asherman’s syndrome is defined as the presence of intrauterine adhesions or fibrosis 
within the uterine cavity that either partially or completely obliterate the cavity. It was 
initially described by Heinrich Fritsch in 1894 and then further characterized by Joseph 
Asherman in 1948. (1) The most common etiology of the disease is dilation and cutterage 
due to pregnancy complications such as incomplete abortion, postpartum hemorrhage, or 
retained placenta. (2, 3) While the disease is rare within the general population, it is 
commonly cited as a factor in pregnancy complications in the infertile population. (4)  
Clinical manifestations of the disease include recurrent pregnancy loss, infertility, 
menstrual abnormalities, and cyclic pelvic pain. (5)  The extent of intrauterine adhesions 
is graded and the severity of disease classified by extent of cavity obliterated, location of 
adhesions within the cavity, and character of the adhesions. (6) The American Society of 
Reproductive Medicine recommends classification of disease based on extent of cavity 
obliterated (<1/3, 1/32/3, >2/3), quality of adhesions seen of hysteroscopy (filmy, filmy 
and dense, dense), and patient’s menstrual pattern (normal, hypomenorrhea, 
amenorrhea).(7)  At present, there are several modalities useful in the screening and 
diagnosis of Asherman’s syndrome. In this chapter, we will discuss these modalities in 
detail, explaining the benefits and drawbacks of each.  We also suggest that three 
dimensional sonography appears to enhance the physician’s ability to provide an accurate 
diagnosis and prognosis to patients with Asherman’s syndrome. 
Traditionally, the diagnosis of Asherman’s syndrome was made by history and physical 
examination. (1) Over time, direct visualization via hysteroscopy, hysterosalpingography, 
and sonography have all led to improved diagnostic accuracy.  The hysterosalpingogram 
(HSG) is a procedure that provides an indirect means of evaluating the uterine cavity, 
since by injecting radio opaque dye transcervically, information can be gathered on the 
location and extent of adhesions. (8) Unfortunately, several studies have shown that 
hysterosalpingogram produces a large number of false positives, specifically in those 
whose cavities contain lesions other than intrauterine adhesions such as cervical stenosis, 
endometrial polyps, and myomas. (8, 9) Another drawback of this procedure is its 
inability to characterize the uterine cavity beyond where the radioopaque dye perfused, 
and thus potentially not identifying lower uterine segment outflow obstructions.  
Therefore, patients with normal cavities except for the presence of adhesions in the lower 
uterine segment will have hysterosalpingograms that appear similar to patients with 
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severe disease, thus having their disease severity incorrectly classified and potentially 
leading to treatment errors. (10)  Furthermore, even in patients who did not have lower 
tract obstruction, HSG over-estimated disease severity compared to three dimensional 
ultrasound due to decreased clarity. (10) 
Sonohysterography is another modality used to survey the uterine cavity for adhesions.  It is a 
simple procedure that involves injecting sterile saline into the uterus to distend the cavity.  The 
saline outlines the cavity aiding the operator in identifying structural abnormalities on the two 
dimensional ultrasound. Unlike hysterosalpingography, sonohysterography does not use 
radiation and can be done in an office setting.  Initially, in small studies and case reports 
sonohysterography was thought to have diagnostic superiority to hysterosalpingography. 
(11,12, 13) However, when a larger study was conducted, it showed that two dimensional 
sonohysterography and hysterosalpingography have similar sensitivities both with high false 
positive rates. (9)  At this point, it was suggested by these authors that the use of three 
dimensional ultrasound may in fact improve sonohysterographic accuracy. (9) 
The use of two dimensional transvaginal ultrasound to identify intrauterine adhesions is  
controversial. In two dimensional ultrasound, sound waves are sent straight and reflected 
back in a linear vector, allowing for an image to be constructed only from the x and y 
planes.  This modality is very operator dependent making its efficacy at diagnosing and 
prognosticating Asherman’s syndrome difficult to accurately assess.  In small  studies, 
sensitivities of 80 to 90 percent for diagnosing intrauterine adhesions have been reported, 
however these numbers have not been reproduced. (14, 15) Rather, in another small series, 
two dimensional transvaginal ultrasound failed to diagnose intrauterine adhesions in any 
of the 4 cases in the study and gave 3 false positive diagnoses. (11)  In a larger study that 
included 209 patients, two dimensional transvaginal ultrasound had a 97% sensitivity and 
11% specificity at identifying intrauterine adhesions.(9) Again suggesting that two 
dimensional transvaginal ultrasound has a high false positive rate but may be useful as a 
screening modality. However, it has been showed that hysterosalpingography is a more 
accurate screening test. (8) 
In three dimensional ultrasound, sound waves are emitted across a sector. The intensity of 
these sounds waves is the same as two dimensional ultrasound.  The returning echoes are 
processed by a sophisticated algorithm resulting in a reconstructed three dimensional 
volume image with x, y, and z planes. This process is very similar to a CT scan.  Three 
dimensional ultrasound allows clinicians to see width, height, and depth of images. A 
Voluson Endocavity transducer S-VDW 5-8 (Kretztechnik AG, Austria) with a center 
frequency of 6.5 MHz connected to a Voluson 530D (Medison, USA) 3D ultrasound 
machine is applied for scanning.   Every examination starts with a 2D evaluation of the 
endometrial cavity. After switching into 3D-mode, the region of interest is selected with 
the volume box and the volume is acquired. When possible, information regarding the 
scan is stored on a 540-MB removable hard disk for further evaluation and calculations 
One of the advantages of three dimensional ultrasound is the real time assessment of the 
uterine cavity.  Unlike hysterosalpingography, three dimensional ultrasound uses no 
radiation and can be done during an office visit.  In a study done by Knopman et al, 54 
infertile patients with suspected Asherman’s syndrome underwent both three 
dimensional ultrasound and hysterosalpingography prior to hysteroscopy.  In this study, 
intrauterine adhesions were demonstrated on three dimensional ultrasound and 
hysterosalpingography in all cases.  However, three dimensional ultrasound had a 
sensitivity of 100% and hysterosalpingography  had a sensitivity of 66.7%. Furthermore, 
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in 61.1% of cases in which hysterosalpingography results were inconsistent with 
hysteroscopy, lower uterine segment outflow tract obstruction was present and the 
hysterosalpingogram misclassified findings as severe disease with complete cavity 
obstruction. (10)  Therefore, as prognosis in patients with Asherman’s syndrome is based 
on severity of disease, it appears from this data that three dimensional ultrasound more 
accurately assesses prognosis, which has strong clinical applications. 
Clinically, many women presenting with fertility problems are found to have Asherman’s 
syndrome during routine infertility work-up.  Knopman et al suggest that because the 
data obtained from three dimensional ultrasound correlates more closely with the 
character and extent of Asherman’s disease, it could be a helpful tool in predicting fertility 
outcome postoperatively.  Furthermore, the high pregnancy rates achieved in their clinic 
may in part be due to the excellent pre-operative information obtained from the three 
dimensional ultrasound, ensuring a well informed surgical procedure.  Three dimensional 
ultrasound has many other uses in obstetrics, gynecology, and reproductive medicine. 
Three dimensional volumetry of the gestational sac in the first trimester has been 
suggested as a sensitive predictor of pregnancy outcome. (16) Additionally, three 
dimensional sonography has been suggested in case reports to be an accurate tool to 
identify multiple gestations in the first trimester. (17) Due to the high risk nature of 
multiple gestation pregnancies, an early assessment of amnionicity and chorionicity is an 
essential part of perinatal management.  In summary, three dimensional ultrasound has 
many promising uses in infertility(18, 19, 20, 21),  early pregnancy (22, 23, 24), and fetal 
malformations (25, 26).  As the technology matures and treating physicians obtain more 
training, skills, and comfort with this technology, we anticipate more widespread 
acceptance and patient benefit to ensue. 
 
 
Fig. 1. Frontal plane demonstratinf a caviy with <10% scarring. Normal cavity with ouflow 
obstruction. 
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Fig. 2. Frontal plane demonstrating about 50% of cavity scarred. Abnoramal cavity without 
ouflow obstruction. 
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